BCAT2 and pancreatic ductal adenocarcinoma: Overexpression of the mutant form of the proto-oncogene GTPase KRAS (KRASG12V) in pancreatic ductal adenocarcinoma (PDAC) samples increases, whereas knockdown of KRAS decreases, BCAT2 protein, with a minimal effect on BCAT2 mRNA level.